[ A20-119] Perampanel (generalized epilepsy) - Benefit assessment according to §35a Social Code Book V
Last updated 15.03.2021
Project no.:
A20-119
Commission:
Commission awarded on 14.12.2020 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Application field:
Children's and adolescents' health
Adjunctive treatment of primary generalized tonic-clonic seizures in children from 7 to < 12 years of age with idiopathic generalized epilepsy
Added benefit not proven.
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
| Project no. | Title | Status |
|---|---|---|
| A20-117 | Perampanel (partial-onset seizures) - Benefit assessment according to §35a Social Code Book V | Commission completed |
| A17-61 | Perampanel (epilepsy) - Benefit assessment according to §35a Social Code Book (SGB) V | Commission completed |
| A14-16 | Perampanel - Benefit assessment according to § 35a Social Code Book V (dossier assessment) | Commission completed |
| A12-12 | Perampanel - Benefit assessment according to § 35a Social Code Book V (dossier assessment) | Commission completed |